Can You Take Pepto-Bismol with Eliquis?
You should avoid taking Pepto-Bismol (bismuth subsalicylate) while on Eliquis (apixaban) due to significantly increased bleeding risk from the salicylate component.
Why This Combination Is Problematic
Pepto-Bismol contains bismuth subsalicylate, where the salicylate portion is extensively absorbed (>90%) from the gastrointestinal tract 1, 2. This creates two major concerns when combined with Eliquis:
Increased Bleeding Risk from Antiplatelet Effects
- The FDA label for Eliquis explicitly warns that coadministration of antiplatelet agents increases bleeding risk 3
- In the ARISTOTLE trial, concomitant aspirin use increased major bleeding rates from 1.8% to 3.4% per year with apixaban 3
- The 2024 ESC guidelines state that combining antiplatelet drugs with anticoagulants should only occur in selected patients with acute vascular disease, not for routine use 4
Salicylate-Specific Interaction
The salicylate component of Pepto-Bismol acts similarly to aspirin by:
- Displacing anticoagulants from plasma protein binding sites 5
- Increasing free (active) drug levels
- Potentiating anticoagulant effects beyond intended therapeutic levels 5
A documented case report demonstrated that bismuth subsalicylate caused a warfarin patient's INR to rise from 2.56 to 3.54 within 3 days, resulting in bleeding from a tracheostomy site 5. While this case involved warfarin, the mechanism of salicylate displacement and antiplatelet effects applies equally to Eliquis.
Clinical Implications
After standard Pepto-Bismol dosing (60 mL), peak plasma salicylate levels reach approximately 40 micrograms/mL 1, which is sufficient to produce clinically significant antiplatelet effects when combined with an anticoagulant.
The maximum daily dose of Pepto-Bismol (4.2 g of bismuth subsalicylate) delivers substantial salicylate exposure 2, creating a dual antiplatelet-anticoagulant regimen that lacks clinical indication and substantially increases hemorrhagic risk.
What to Use Instead
For gastrointestinal symptoms while on Eliquis:
- Non-salicylate antacids (calcium carbonate, magnesium hydroxide)
- Proton pump inhibitors or H2-receptor antagonists for acid-related symptoms
- Loperamide for diarrhea (does not contain salicylates)
Important Caveats
- If Pepto-Bismol has already been taken, monitor closely for bleeding signs (unusual bruising, blood in stool/urine, prolonged bleeding from cuts)
- Salicylate can continue to be excreted for days after discontinuation 1
- Many over-the-counter products contain hidden salicylates—always check active ingredients
- The guideline recommendation against adding antiplatelet treatment to anticoagulation in AF patients is Class III (harm) 4